Author Correction: Combining DNMT and HDAC6 inhibitors increases anti-tumor immune signaling and decreases tumor burden in ovarian cancer.
Moufarrij S, Srivastava A, Gomez S, Hadley M, Palmer E, Austin PT, Chisholm S, Diab N, Roche K, Yu A, Li J, Zhu W, Lopez-Acevedo M, Villagra A, Chiappinelli KB.
Moufarrij S, et al.
Sci Rep. 2021 Dec 20;11(1):24423. doi: 10.1038/s41598-021-04066-1.
Sci Rep. 2021.
PMID: 34931014
Free PMC article.
No abstract available.